We are live on ! Find out more
VAM

Veritas Asset Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 3.19%
This Fund
S&P 500
This Quarter Est. Return
-15.93%
1 Year Est. Return
-3.19%
3 Year Est. Return
+26.61%
5 Year Est. Return
+23.16%
10 Year Est. Return
+201.18%
AUM
$13.4B
AUM Growth
-$2.93B
Cap. Flow
-$230M
Cap. Flow %
-1.72%
Top 10 Hldgs %
67.02%
Holding
38
New
3
Increased
6
Reduced
27
Closed

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$399M
2
ILMN icon
Illumina
ILMN
+$247M
3
COO icon
Cooper Companies
COO
+$173M
4
AMZN icon
Amazon
AMZN
+$75.8M
5
EMBC icon
Embecta
EMBC
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.66%
2 Communication Services 24.48%
3 Technology 11.65%
4 Industrials 8.9%
5 Financials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.23T
$1.31B 9.78%
12,027,060
-896,700
-7% -$106M
CHTR icon
2
Charter Communications
CHTR
$16.2B
$1.21B 9%
2,573,583
-64,448
-2% -$31.4M
CP icon
3
Canadian Pacific Kansas City
CP
$83.2B
$1.16B 8.67%
16,633,390
-577,681
-3% -$41.8M
FISV
4
Fiserv Inc
FISV
$27B
$861M 6.42%
9,677,622
-343,594
-3% -$33.3M
CVS icon
5
CVS Health
CVS
$137B
$790M 5.9%
8,526,923
-6,150,861
-42% -$600M
META icon
6
Meta Platforms (Facebook)
META
$1.64T
$764M 5.7%
4,740,266
-124,120
-3% -$23.9M
CTLT
7
DELISTED
CATALENT, INC.
CTLT
$739M 5.52%
6,892,041
-107,645
-2% -$11M
BAX icon
8
Baxter International
BAX
$11.7B
$734M 5.48%
11,426,694
-886,867
-7% -$64.4M
UNH icon
9
UnitedHealth
UNH
$387B
$731M 5.45%
1,422,406
-35,280
-2% -$17.7M
MA icon
10
Mastercard
MA
$480B
$684M 5.1%
2,167,931
-56,534
-3% -$19.5M
MSFT icon
11
Microsoft
MSFT
$2.93T
$680M 5.07%
2,647,399
-70,575
-3% -$19.2M
COO icon
12
Cooper Companies
COO
$14B
$644M 4.8%
8,221,224
+1,956,472
+31% +$173M
AMZN icon
13
Amazon
AMZN
$2.66T
$600M 4.48%
5,651,487
+605,787
+12% +$75.8M
BDX icon
14
Becton Dickinson
BDX
$43.6B
$593M 4.42%
2,404,270
-222,433
-8% -$56.5M
TMO icon
15
Thermo Fisher Scientific
TMO
$198B
$394M 2.94%
724,484
-13,820
-2% -$7.61M
BIO icon
16
Bio-Rad Laboratories Class A
BIO
$8.15B
$380M 2.83%
+766,762
New +$399M
ILMN icon
17
Illumina
ILMN
$28.2B
$288M 2.15%
1,607,232
+965,982
+151% +$247M
ICE icon
18
Intercontinental Exchange
ICE
$79B
$260M 1.94%
2,760,543
-38,075
-1% -$4.07M
CSGP icon
19
CoStar Group
CSGP
$12.2B
$243M 1.81%
4,017,400
-1,164,570
-22% -$70.5M
MCO icon
20
Moody's
MCO
$89.2B
$150M 1.12%
551,772
-10,734
-2% -$3.21M
SE icon
21
Sea Limited
SE
$63.7B
$54.4M 0.41%
813,502
+10,000
+1% +$852K
PM icon
22
Philip Morris
PM
$301B
$21M 0.16%
212,433
-85,635
-29% -$8.73M
MSM icon
23
MSC Industrial Direct
MSM
$6.97B
$17.4M 0.13%
231,457
-58,143
-20% -$4.77M
FNV icon
24
Franco-Nevada
FNV
$38.7B
$16.5M 0.12%
125,186
+21,300
+21% +$3.15M
CSCO icon
25
Cisco
CSCO
$441B
$15.3M 0.11%
359,561
-113,239
-24% -$5.42M

Similar funds

Veritas Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Veritas Asset Management held 38 positions worth $13.4B, down 18% from $16.3B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Veritas Asset Management's Q2 2022 filing shows 3 new, 6 increased and 27 reduced positions. Its largest new stake was Bio-Rad Laboratories Class A: 766,762 shares worth $380M. The largest sale was CVS Health, an estimated $600M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 37% a quarter earlier, followed by Communication Services and Technology.

  • Veritas Asset Management's largest Q2 2022 buy was Bio-Rad Laboratories Class A: 766,762 shares worth $380M.
  • Veritas Asset Management added most to Illumina in Q2 2022, an estimated $247M increase.
  • Veritas Asset Management's biggest Q2 2022 reduction was CVS Health, cutting an estimated $600M.
  • Veritas Asset Management's ten largest holdings make up 67% of its $13.4B portfolio in Q2 2022.
  • Veritas Asset Management opened 3 new positions and closed 0 in Q2 2022.
  • Veritas Asset Management's portfolio value fell 18% quarter-over-quarter to $13.4B.

Based on Veritas Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.